Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Inclusion Criteria: Each subject must: Be able and willing to provide written informed consent and sign a Health Information Portability and Accountability Act (HIPAA) form prior to any study procedure being performed; Be able and willing to follow all instructions and attend all study visits; Be 45-75 years of age of either sex and any race or ethnicity; Be presbyopic in both eyes; Exclusion Criteria: Each subject must not: Have known contraindications or sensitivity to the use of the investigational drug or its components, or any other medications required by the protocol; Have any active systemic or ocular disorder other than refractive disorder; Have prior, current or anticipated use of any contact lenses during study participation; Have presence of any abnormality of the lids, ocular surface, or lacrimal duct system that could affect ophthalmic drop absorption; Have anticipated inability to stay confined on required study days;